Abstract:Abstract Background Atherosclerosis is a chronic lipid-driven inflammatory disease with infiltration of low-density lipoprotein and is considered as the pivotal step in plaque formation. The aim of the review is to get into the fine details of pathophysiologic mechanisms responsible for atherosclerosis with atherosclerotic lesion classification. It also provides a summary of current biomarkers other than the traditional risk factors so that new treatment modalities can emerge and reduce the morbidity and mortality associated with atherosclerosis. Main body In the classification of atherosclerosis made by American Heart Association (AHA), AHA Type I lesion is the earliest vascular change described microscopically. AHA Type II lesion is primarily composed of abundant macrophages. AHA Type III lesion is the earliest of progressive lesions, while AHA Type IV lesion consists of an acellular necrotic core. Various biomarkers are implicated in different stages of the pathophysiological mechanism of plaque formation and evolution. C Reactive Protein plays a direct role in promoting the inflammatory component of atherosclerosis. Fibrinogen was demonstrated to be elevated among patients with acute thrombosis. Higher leukocyte count is associated with a greater cardiovascular risk. Cytokines have been implicated in atheroma formation and complications. High rates of protease activated receptor expression are also induced by interleukin-6 secretion in atherosclerotic lesions and areas of vascular tissue injury. Cluster of differentiation 40 receptor and its ligand have been also detected in atherosclerotic plaques. Osteopontin, acidic phosphoprotein, and osteoprotegerin have emerged as novel markers of atherosclerotic plaque composition. There are also overproductions of matrix metalloproteinases in the rupture-prone regions and promote lipid-necrotic core formation in the atherosclerotic plaque. Myeloperoxidase has been proposed as a marker of plaque instability. Oxidized low-density lipoprotein receptor 1 provides a route of entry for oxidized low-density lipoprotein into the endothelium. A human atherosclerotic lesion also expresses lipoprotein-associated phospholipase A 2 . Short conclusion Atherosclerotic plaques are the battlefield between an unbalanced immune response and lipid accumulation in the intima of arteries. Most of the biomarkers associated with atherosclerosis are indicators of inflammatory response and will also be used for medical purposes.

The Research Progress of Tissue Proteomics in Atherosclerotic Disease

Omics research in atherosclerosis

New Progress in Early Diagnosis of Atherosclerosis

Mechanistic insights into the regression of atherosclerotic plaques

The cellular biology of atherosclerosis with atherosclerotic lesion classification and biomarkers

Epigenetic Regulation in Pathology of Atherosclerosis: A Novel Perspective

Proteomics in atherothrombosis: a future perspective

Research Progress of Adipokines Gene Polymorphism and Atherosclerosis of Coronary Artery

Global Transcriptomic Study of Atherosclerosis Development in Rats

Proteomics applications in biomarker discovery and pathogenesis for abdominal aortic aneurysm

Research Progress of Pathogenesis of Atherosclerosis

Proteomic and Metabolomic Analyses of Atherosclerotic Vessels from Apolipoprotein E-Deficient Mice Reveal Alterations in Inflammation, Oxidative Stress, and Energy Metabolism

Targeted Imaging in Atherosclerosis.

Identification of Key Candidate Biomarkers and Pathways in Atherosclerosis

Common molecular mechanism and immune infiltration patterns of thoracic and abdominal aortic aneurysms

Atherosclerosis: Known and unknown

Omics Approaches Unveiling the Biology of Human Atherosclerotic Plaques

The Pathological Factors Involved in Current in Vitro Atherosclerotic Models

Targeted intervention of natural medicinal active ingredients and traditional Chinese medicine on epigenetic modification: possible strategies for prevention and treatment of atherosclerosis

Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability

Understanding the Intricacies of Cellular Senescence in Atherosclerosis: Mechanisms and Therapeutic Implications